Uncovering the Truth: Bowlero Corp Under Investigation – Johnson Fistel Pursues Justice for Investors Following Stock Decline

Bowlero Corp. Subject to Investigation: Johnson Fistel Seeks Remedies for Investors After the Stock Drop SAN DIEGO, May 19, 2023 (GLOBE NEWSWIRE) — Johnson Fistel, LLP, a shareholder rights law firm, is investigating Bowlero Corp. (“Bowlero” or “the Company”) (NYSE: BOWL) to determine whether investors who suffered significant losses on their investment may be able…

Read More

Get Ready to Geek Out: Liquidia Takes the Stage at the 2023 American Thoracic Society Conference!

Welcome to the Liquidia Corporation Poster Presentation! Get Ready for a Breath of Fresh Air Hey there fellow lung enthusiasts! Have you heard the news? Liquidia Corporation is gearing up to present some exciting data on the investigational use of YUTREPIA™ (treprostinil) inhalation powder at the 2023 American Thoracic Society International Conference. Cue the confetti…

Read More

Unlocking Success: Aclarion’s Non-Convertible Debt Financing for Three Vital Catalysts

Unlocking Success: Aclarion’s Non-Convertible Debt Financing for Three Vital Catalysts Up to $2M Unsecured, Non-Convertible Bridge Debt With No Required Amortization Payments Financing Supports Execution of the 2023 Plan and the Achievement of Critical Milestones in Support of Definitive Growth Capital BROOMFIELD, CO, May 19, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Aclarion, Inc., (“Aclarion”…

Read More

Unveiling Innovation: Liquidia’s Poster Presentation at the 2023 American Conference

Liquidia Corporation to Present Data on YUTREPIA™ at ATS International Conference MORRISVILLE, N.C., May 19, 2023 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced the Company will present data related to the investigational use of YUTREPIA™ (treprostinil) inhalation powder at the 2023 American Thoracic Society (ATS) International Conference, taking place…

Read More